Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein

被引:14
|
作者
Keskitalo, Salla
Tammela, Tuomas
Lyytikka, Johannes
Karpanen, Terhi
Jeltsch, Michael
Markkanen, Johanna
Yla-Herttuala, Seppo
Alitalo, Kari
机构
[1] Biomedicum Helsinki, Haartman Inst, Mol Canc Biol Lab, Helsinki, Finland
[2] Biomedicum Helsinki, Haartman Inst, Ludwig Inst Canc Res, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Univ Kuopio, AI Virtanen Inst, FIN-70211 Kuopio, Finland
[5] Univ Kuopio, Dept Med, FIN-70211 Kuopio, Finland
关键词
proangiogenic therapy; gene therapy; growth factors;
D O I
10.1161/01.RES.0000269042.58594.f6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF)-C and VEGF-D require proteolytic cleavage of the carboxy terminal silk-homology domain for activation. To study the functions of the VEGF-C propeptides, we engineered a chimeric growth factor protein, VEGF-CAC, composed of the amino- and carboxy-terminal propeptides of VEGF-C fused to the receptor-activating core domain of VEGF. Like VEGF-C, VEGF-CAC underwent proteolytic cleavage, and like VEGF, it bound to and activated VEGF receptor-1 and VEGF receptor- 2, but not the VEGF-C receptor VEGF receptor-3. VEGF-CAC also bound to neuropilins in a heparin-dependent manner. Strikingly, when VEGF-CAC was expressed via an adenovirus vector in the ear skin of immunodeficient mice, it proved to be a more potent inducer of capillary angiogenesis than VEGF. The VEGF-CAC-induced vessels differed greatly from those induced by VEGF, as they formed a very dense and fine network of pericyte and basement membrane-covered capillaries that were functional, as shown by lectin perfusion experiments. VEGF-CAC could prove useful in proangiogenic therapies in patients experiencing tissue ischemia.
引用
收藏
页码:1460 / 1467
页数:8
相关论文
共 50 条
  • [21] Vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 as predictors of lymphatic metastasis in stage a testis cancer
    Unni, R
    Jung, CY
    Ulbright, TM
    Mosharafa, AA
    Donohue, JP
    Foster, RS
    JOURNAL OF UROLOGY, 2004, 171 (04): : 310 - 310
  • [22] Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis
    Zhao, Tieqiang
    Zhao, Wenyuan
    Meng, Weixin
    Liu, Chang
    Chen, Yuanjian
    Sun, Yao
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 306 (06): : H789 - H796
  • [23] Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
    Carmeliet, P
    Collen, D
    VASCULAR GROWTH FACTORS AND ANGIOGENESIS, 1999, 237 : 133 - 158
  • [24] Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma
    Kojima, H
    Shijubo, N
    Yamada, G
    Ichimiya, S
    Abe, S
    Satoh, M
    Sato, N
    CANCER, 2005, 104 (08) : 1668 - 1677
  • [25] A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities
    Joukov, V
    Kumar, V
    Sorsa, T
    Arighi, E
    Weich, H
    Saksela, O
    Alitalo, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) : 6599 - 6602
  • [26] Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion
    Hlophe, Yvette N.
    Joubert, Anna M.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (23) : 5743 - 5754
  • [27] Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer
    Nakashima, T
    Huang, C
    Liu, DG
    Kameyama, K
    Masuya, D
    Ueno, M
    Haba, R
    Yokomise, H
    MEDICAL SCIENCE MONITOR, 2004, 10 (06): : BR157 - BR165
  • [28] Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
    Ristimäki, A
    Narko, K
    Enholm, B
    Joukov, V
    Alitalo, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) : 8413 - 8418
  • [29] Matrix stiffness primes lymphatic tube formation directed by vascular endothelial growth factor-C
    Alderfer, Laura
    Russo, Elizabeth
    Archilla, Adriana
    Coe, Brian
    Hanjaya-Putra, Donny
    FASEB JOURNAL, 2021, 35 (05):
  • [30] Role of vascular endothelial growth factor-C in experimental obliterative airway disease
    Krebs, R.
    Tikkanen, J. M.
    Nykanen, A. L.
    Alitalo, K.
    Yla-Herttuala, S.
    Koskinen, P. K.
    Lemstrom, K. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S70 - S70